Table 2.
Group characteristics
| HO/NAFL | Borderline | NASH | P-value | |
|---|---|---|---|---|
| n | 32 | 24 | 28 | |
| Age [years] | 42.8 ± 12 | 39.5 ± 12 | 41.1 ± 9.5 | 0.55 |
| Weight [kg] | 148 ± 28.5 | 156 ± 23.8 | 163 ± 32.8 | 0.13 |
| Height [cm] | 173 ± 12 | 173 ± 10 | 174 ± 12 | 0.99 |
| BMI [kg/m2] | 49.2 ± 8.4 | 51.7 ± 5.8 | 53.8 ± 8.2 | 0.07 |
| Women [n/%] | 22/68.75 | 16/66.7 | 20/71.4 | 0.93 |
| Men [n/%] | 10/31.25 | 8/33.3 | 8/28.6 | 0.93 |
| Type 2 diabetes [n/%] | 9/28.1 | 10/41.7 | 19/67.9 | 0.01 |
| Hypertension [n/%] | 18/56.3 | 12/50 | 21/75 | 0.15 |
| Dyslipidemia [n/%] | 14/43.8 | 20/83.3 | 26/92.9 | < 0.001 |
| OSAS [n/%] | 10/31.3 | 7/29.2 | 8/28.6 | 0.78 |
| NAS | 0.8 ± 0.8 | 3.5 ± 0.5 | 5.6 ± 0.8 | < 0.001 |
| MMP9 [µg/mL] | 8.1 ± 3.5 | 9.1 ± 3.7 | 12.6 ± 6.5 | 0.002 |
| FABP4 [ng/mL] | 25.2 ± 9.1 | 31 ± 18.5 | 34.6 ± 26.8 | 0.166 |